{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:37Z","timestamp":1791921097081,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07452-x","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:13:10Z","timestamp":1790597590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nine-year ocular developmental outcomes after ranibizumab or laser treatment for zone II retinopathy of prematurity: follow-up of a randomized trial cohort"],"prefix":"10.1007","volume":"185","author":[{"given":"Yaling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laijiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guishuang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"4S","key":"7452_CR1","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.ophtha.2019.11.026","volume":"127","author":"WV Good","year":"2020","unstructured":"Good WV (2020) Retinopathy of prematurity incidence in children. Ophthalmology 127(4S):S82\u2013S83","journal-title":"Ophthalmology"},{"issue":"10208","key":"7452_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A et al (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 394(10208):1551\u20131559","journal-title":"Lancet"},{"issue":"2","key":"7452_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","volume":"153","author":"T Sato","year":"2012","unstructured":"Sato T, Wada K, Arahori H et al (2012) Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153(2):327\u201333 e1","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"7452_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial [J]. JAMA Ophthalmol 132(11):1327\u20131333","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"7452_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","volume":"125","author":"D Lepore","year":"2018","unstructured":"Lepore D, Quinn GE, Molle F et al (2018) Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings. Ophthalmology 125(2):218\u201326","journal-title":"Ophthalmology"},{"issue":"4","key":"7452_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/IAE.0000000000001241","volume":"37","author":"G Zhang","year":"2017","unstructured":"Zhang G, Yang M, Zeng J et al (2017) Comparison of intravitreal injection of ranibizumab versus laser therapy for zone II treatment-requiring retinopathy of prematurity [J]. Retina 37(4):710\u2013717","journal-title":"Retina"},{"issue":"10","key":"7452_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow N, Stahl A, Lepore D et al (2021) 2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health 5(10):698\u2013707","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"7452_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/bjophthalmol-2019-314610","volume":"104","author":"YC Chen","year":"2020","unstructured":"Chen YC, Chen SN (2020) Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation. Br J Ophthalmol 104(5):691\u20136","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"7452_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamaophthalmol.2017.3431","volume":"135","author":"J Lei","year":"2017","unstructured":"Lei J, Durbin MK, Shi Y et al (2017) Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images. JAMA Ophthalmol 135(10):1092\u20131098","journal-title":"JAMA Ophthalmol"},{"key":"7452_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/OPTH.S104721","volume":"10","author":"N Nakamura","year":"2016","unstructured":"Nakamura N, Fujinami K, Mizuno Y et al (2016) Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device. Clin Ophthalmol 10:1175\u20131185","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"7452_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL Mcculloch","year":"2015","unstructured":"Mcculloch DL, Marmor MF, Brigell MG et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1\u201312","journal-title":"Doc Ophthalmol"},{"key":"7452_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep30523","volume":"6","author":"Y Yaguchi","year":"2016","unstructured":"Yaguchi Y, Katagiri S, Fukushima Y et al (2016) Electroretinographic effects of retinal dragging and retinal folds in eyes with familial exudative vitreoretinopathy. Sci Rep 6:30523","journal-title":"Sci Rep"},{"key":"7452_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102567","volume":"71","author":"N Marlow","year":"2024","unstructured":"Marlow N, Reynolds JD, Lepore D et al (2024) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial. EClinicalMedicine 71:102567","journal-title":"EClinicalMedicine"},{"issue":"9","key":"7452_CR14","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1136\/bjophthalmol-2018-312272","volume":"103","author":"HG Kang","year":"2019","unstructured":"Kang HG, Choi EY, Byeon SH et al (2019) Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety. Br J Ophthalmol 103(9):1332\u20131336","journal-title":"Br J Ophthalmol"},{"key":"7452_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","volume":"192","author":"YS Lee","year":"2018","unstructured":"Lee YS, See LC, Chang SH et al (2018) Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment. Am J Ophthalmol 192:20\u201330","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"7452_CR16","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1097\/IAE.0000000000002301","volume":"39","author":"S Balasubramanian","year":"2019","unstructured":"Balasubramanian S, Borrelli E, Lonngi M et al (2019) Visual function and optical coherence tomography angiography features in children born preterm. Retina 39(11):2233\u20132239","journal-title":"Retina"},{"issue":"4","key":"7452_CR17","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.4.14","volume":"10","author":"M Simmons","year":"2021","unstructured":"Simmons M, Wang J, Leffler JN et al (2021) Longitudinal development of refractive error in children treated with intravitreal bevacizumab or laser for retinopathy of prematurity. Transl Vis Sci Technol 10(4):14","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"7452_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2006.02.018","volume":"142","author":"JT Flynn","year":"2006","unstructured":"Flynn JT, Chan-Ling T (2006) Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am J Ophthalmol 142(1):46\u201359","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"7452_CR19","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","volume":"119","author":"WC Wu","year":"2012","unstructured":"Wu WC, Lin RI, Shih CP et al (2012) Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 119(9):1907\u201316","journal-title":"Ophthalmology"},{"issue":"1","key":"7452_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bjo.81.1.2","volume":"81","author":"AR Fielder","year":"1997","unstructured":"Fielder AR, Quinn GE (1997) Myopia of prematurity: nature, nurture, or disease? Br J Ophthalmol 81(1):2\u20133","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"7452_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ophtha.2018.07.030","volume":"126","author":"S Balasubramanian","year":"2019","unstructured":"Balasubramanian S, Beckmann J, Mehta H et al (2019) Relationship between retinal thickness profiles and visual outcomes in young adults born extremely preterm: the EPICure@19 Study [J]. Ophthalmology 126(1):107\u2013112","journal-title":"Ophthalmology"},{"issue":"11","key":"7452_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jamaophthalmol.2013.5052","volume":"131","author":"WC Wu","year":"2013","unstructured":"Wu WC, Shih CP, Wang NK et al (2013) Choroidal thickness in patients with a history of retinopathy of prematurity. JAMA Ophthalmol 131(11):1451\u20131458","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"7452_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.oret.2020.09.004","volume":"5","author":"S Mangalesh","year":"2021","unstructured":"Mangalesh S, Mcgeehan B, Tai V et al (2021) Macular OCT characteristics at 36 weeks\u2019 postmenstrual age in infants examined for retinopathy of prematurity. Ophthalmol Retina 5(6):580\u2013592","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"7452_CR24","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.1111\/aos.14324","volume":"98","author":"A Lavric","year":"2020","unstructured":"Lavric A, Tekavcic Pompe M, Markelj S et al (2020) Choroidal structural changes in preterm children with and without retinopathy of prematurity. Acta Ophthalmol 98(5):e611\u2013e6","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"7452_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000484631","volume":"60","author":"W Bowl","year":"2018","unstructured":"Bowl W, Bowl M, Schweinfurth S et al (2018) Choroidal thickness with swept-source optical coherence tomography versus foveal morphology in young children with a history of prematurity. Ophthalmic Res 60(4):205\u2013213","journal-title":"Ophthalmic Res"},{"issue":"11","key":"7452_CR26","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1167\/iovs.06-1199","volume":"48","author":"M Ecsedy","year":"2007","unstructured":"Ecsedy M, Szamosi A, Karko C et al (2007) A comparison of macular structure imaged by optical coherence tomography in preterm and full-term children [J]. Invest Ophthalmol Vis Sci 48(11):5207\u20135211","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7452_CR27","doi-asserted-by":"publisher","first-page":"86 e1","DOI":"10.1016\/j.jaapos.2020.01.007","volume":"24","author":"TL Lenis","year":"2020","unstructured":"Lenis TL, Gunzenhauser RC, Fung SSM et al (2020) Myopia and anterior segment optical coherence tomography findings in laser-treated retinopathy of prematurity eyes. J AAPOS 24(2):86 e1-e7","journal-title":"J AAPOS"},{"key":"7452_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajo.2023.04.014","volume":"252","author":"AK Curran","year":"2023","unstructured":"Curran AK, Stukin J, Ambrosio L et al (2023) Electroretinographic responses in retinopathy of prematurity treated using intravitreal bevacizumab or laser. Am J Ophthalmol 252:275\u201385","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"7452_CR29","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.3.6.7","volume":"3","author":"H Akerblom","year":"2014","unstructured":"Akerblom H, Andreasson S, Larsson E et al (2014) Photoreceptor function in school-aged children is affected by preterm birth. Transl Vis Sci Technol 3(6):7","journal-title":"Transl Vis Sci Technol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07452-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07452-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07452-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:36:44Z","timestamp":1791920204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07452-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["7452"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07452-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This follow-up study was approved by the Ethics Committee of Shenzhen Eye Hospital. All institutions abided by the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents of all enrolled infants.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been approved for publication by the authors.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"779"}}